PASTEUR Act Introduced In U.S. Senate Aiming To Reinvigorate Innovation For Development Of New Antibiotics

Pew Charitable Trust: New Bill Aims to Jump-Start Development of Urgently Needed Antibiotics
Wes Kim, senior officer for the Antibiotic Resistance Project, discusses the Pioneering Antimicrobial Subscriptions to End Up Surging Resistance Act of 2020, also known as the PASTEUR Act, which was introduced in the Senate at the end of September and “aims to jump-start the development of urgently needed new antibiotics, specifically those that can address unmet patient needs, by changing the way the U.S. government pays for them.” Kim notes, “Passage of the PASTEUR Act would be a major step toward reinvigorating innovation in development of urgently needed new antibiotics. The legislation offers policymakers a clear path to ensure that the U.S. has access to effective antibiotics, and Pew urges Congress to pass it as soon as possible” (11/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.